Study of 18F-FFNP Breast PET/MRI
NCT: NCT06086704 · RECRUITING
Brief Summary
This clinical trial will investigate an estrogen-regulated parameter as an early measure of endocrine therapy response: progesterone receptor (PR) protein with a progestin-based radioligand, 18F-fluorofuranylnorprogesterone (18F-FFNP). The overall purpose of this research is to test the efficacy of 18F-FFNP PET/MRI for predicting response to presurgical endocrine therapy and to determine the quantitative reliability of 18F-FFNP breast PET/MRI in patients with newly diagnosed PR+ primary breast cancer.
Frequently Asked Questions
What is Study of 18F-FFNP Breast PET/MRI?
Study of 18F-FFNP Breast PET/MRI is a clinical trial registered under NCT06086704. Current status: RECRUITING.
What is the status of NCT06086704?
The current status of NCT06086704 (Study of 18F-FFNP Breast PET/MRI) is: RECRUITING.
When did Study of 18F-FFNP Breast PET/MRI start?
Study of 18F-FFNP Breast PET/MRI started on 2024-09-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.